Home › Pulmonary Hypertension › California › Sacramento
Pulmonary Hypertension clinical trials in Sacramento, CA
4 studies for Pulmonary Hypertension are looking for participants at sites in and around Sacramento (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
RecruitingObservational study
- UC Davis Health Medical Center, Sacramento
Dopamine vs. Norepinephrine for Hypotension in Neonates With Pulmonary Hypertension (DONE)
RecruitingPhase 4
- UC Davis Children's Hospital, Sacramento
Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
Recruiting
- Sutter Medical Center, Sacramento
Pulmonary Hypertension Association Registry
RecruitingObservational study
- UC Davis Health, Sacramento
About Pulmonary Hypertension
Pulmonary hypertension (PH) is high blood pressure in the arteries to your lungs. It makes your heart work harder, which can lead to heart failure.
More about Pulmonary Hypertension on MedlinePlus
Pulmonary Hypertension trials in other cities
- Philadelphia, PA10 studies
- Aurora, CO9 studies
- Phoenix, AZ9 studies
- Cincinnati, OH8 studies
- Indianapolis, IN8 studies
- Boston, MA8 studies
- New York City, NY8 studies
- Kansas City, KS8 studies
- Charleston, SC7 studies
- Rochester, MN7 studies
- Houston, TX7 studies
- Salt Lake City, UT7 studies
Other studies in Sacramento
- Non-Small Cell Lung Cancer29 studies
- Lung Cancer22 studies
- Breast Cancer20 studies
- Prostate Cancer19 studies
- Metastatic Cancer16 studies
- Acute Myeloid Leukemia12 studies
- Heart Failure12 studies
- Pancreatic Cancer12 studies
- Cancer (all types)11 studies
- Colon Cancer11 studies
- Bladder Cancer10 studies
- Colorectal Cancer10 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.